Shiga toxins (Stxs) produced by enterohaemorrhagic Escherichia coli or Shigella dysenteriae damage human endothelial cells predominantly in cooperation with pro-inflammatory cytokines, such as TNF-α. However, in this study, in vitro IFN-γ pre-treatment resulted in human lung microvascular endothelial cells becoming over 10 000-fold less sensitive to Stxs. In contrast, in their basal condition, they were extremely sensitive to Stxs. Interestingly, TNF-α addition to IFN-γ reverted the Stx-resistant phenotype, which corresponded with its well-established enhancing effect on Stx toxicity. Toxin binding to the cell was barely affected by IFN-γ. Also, the toxin uptake in the Stx-resistant phenotype was more than 100-fold greater than that of normal cells, when compared at Stx concentrations resulting in equivalent degrees of cell damage. Protein synthesis was inhibited by nearly 90 % in the Stx-resistant phenotype after 24 h toxin exposure. This indicated that the intracellular toxin was active as an N-glycosidase, while cells were still over 60 % viable, suggesting a possible unknown cytotoxic function of Stx. In conclusion, this study shows a unique effect of IFN-γ in the suppression of the toxicity of Stxs in a human microvascular endothelial cell model and the involvement of a novel mechanism in this suppression.
ArabS.,
LingwoodC. A.1998; Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol 177:646–660
BanatvalaN.,
GriffinP. M.,
GreeneK. D.,
BarrettT. J.,
BibbW. F.,
GreenJ. H.,
WellsJ. G.Hemolytic Uremic Syndrome Study Collaborators2001; The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063–1070
BhimmaR.,
RollinsN. C.,
CoovadiaH. M.,
AdhikariM.1997; Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Pediatr Nephrol 11:560–564
DecludtB.,
BouvetP.,
Mariani-KurkdjianP.,
GrimontF.,
GrimontP. A.,
HubertB.,
LoiratC.2000; Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Societe de Nephrologie Pediatrique. Epidemiol Infect 124:215–220
EndoY.,
TsurugiK.,
YutsudoT.,
TakedaY.,
OgasawaraT.,
IgarashiK.1988; Site of action of a Vero toxin (VT2) from Escherichia coli O157 : H7 and of Shiga toxin on eukaryotic ribosomes. RNA N -glycosidase activity of the toxins. Eur J Biochem 171:45–50
KarmaliM. A.,
PetricM.,
LimC.,
FlemingP. C.,
ArbusG. S.,
LiorH.1985; The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli . J Infect Dis 151:775–782
KeuschG. T.,
AchesonD. W.,
AalderingL.,
ErbanJ.,
JacewiczM. S.1996; Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. J Infect Dis 173:1164–1170
KondoF.,
KobayashiS.,
MatsumotoK.,
YamadaS.,
SaitoM.,
SuzukiY.,
IshikawaN.,
NakanishiT.,
ShimizuA.1997; Analysis of Vero toxins 1 and 2 by high-performance liquid chromatography/electrospray ionization mass spectrometry. J Mass Spectrom 32:1140–1142
LaurenceJ.,
MitraD.1997; Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome. Semin Hematol 34:98–105
MolostvovG.,
MorrisA.,
RoseP.,
BasuS.2001; Interaction of cytokines and growth factor in the regulation of verotoxin-induced apoptosis in cultured human endothelial cells. Br J Haematol 113:891–897
OhmiK.,
KiyokawaN.,
TakedaT.,
FujimotoJ.1998; Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Biochem Biophys Res Commun 251:137–141
PijpersA. H.,
van SettenP. A.,
van den HeuvelL. P.,
AssmannK. J.,
DijkmanH. B.,
PenningsA. H.,
MonnensL. A.,
van HinsberghV. W.2001; Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Nephrol 12:767–778
SieglerR. L.,
PysherT. J.,
TeshV. L.,
TaylorF. B.Jr2001; Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome. J Am Soc Nephrol 12:1458–1467
TaylorF. B.Jr,
TeshV. L.,
DeBaultL.,
LiA.,
ChangA. C.,
KosankeS. D.,
PysherT. J.,
SieglerR. L.1999; Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 154:1285–1299
van de KarN. C.,
MonnensL. A.,
KarmaliM. A.,
van HinsberghV. W.1992; Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755–2764
WandersR. J. A.,
RomeynG. J.,
SchutgensR. B. H.,
TagerJ. M.1989; l-Pipecolate oxidase: a distinct peroxisomal enzyme in man. Biochem Biophys Res Commun 164:550–555
WangJ. H.,
RedmondH. P.,
WatsonR. W.,
CondronC.,
Bouchier-HayesD.1999; Involvement of tyrosine protein kinase in IFN-gamma-induced human endothelial cell apoptosis. Shock 11:311–318
YoshidaT.,
FukadaM.,
KoideN.,
IkedaH.,
SugiyamaT.,
KatoY.,
IshikawaN.,
YokochiT.1999; Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis. J Infect Dis 180:2048–2052